GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lincoln Pharmaceuticals Ltd (BOM:531633) » Definitions » Market Cap

Lincoln Pharmaceuticals (BOM:531633) Market Cap : ₹11,059 Mil (As of Apr. 15, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Lincoln Pharmaceuticals Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Lincoln Pharmaceuticals's share price for the quarter that ended in Dec. 2024 was ₹787.25. Lincoln Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 20 Mil. Therefore, Lincoln Pharmaceuticals's market cap for the quarter that ended in Dec. 2024 was ₹15,769 Mil.

Lincoln Pharmaceuticals's quarterly market cap increased from Jun. 2024 (₹12,262 Mil) to Sep. 2024 (₹13,416 Mil) and increased from Sep. 2024 (₹13,416 Mil) to Dec. 2024 (₹15,769 Mil).

Lincoln Pharmaceuticals's annual market cap increased from Mar. 2022 (₹6,230 Mil) to Mar. 2023 (₹6,784 Mil) and increased from Mar. 2023 (₹6,784 Mil) to Mar. 2024 (₹11,726 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Lincoln Pharmaceuticals's Enterprise Value for Today is ₹9,069 Mil.


Lincoln Pharmaceuticals Market Cap Historical Data

The historical data trend for Lincoln Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lincoln Pharmaceuticals Market Cap Chart

Lincoln Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,676.00 4,494.00 6,230.33 6,784.16 11,725.56

Lincoln Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,201.27 11,725.56 12,262.37 13,416.09 15,768.62

Competitive Comparison of Lincoln Pharmaceuticals's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Lincoln Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lincoln Pharmaceuticals's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lincoln Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where Lincoln Pharmaceuticals's Market Cap falls into.


;
;

Lincoln Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Lincoln Pharmaceuticals's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )=Share Price (A: Mar. 2024 )*Shares Outstanding (EOP) (A: Mar. 2024 )
=₹585.4*20.030
=₹11,726

Lincoln Pharmaceuticals's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=₹787.25*20.030
=₹15,769

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lincoln Pharmaceuticals  (BOM:531633) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Lincoln Pharmaceuticals Market Cap Related Terms

Thank you for viewing the detailed overview of Lincoln Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Lincoln Pharmaceuticals Business Description

Traded in Other Exchanges
Address
Science City Road, Lincoln House, Behind Satyam Complex, Sola, Ahmedabad, GJ, IND, 380060
Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin, analgesics, anesthetics, anti-pyretic, GIT products, vitamin-minerals, and iron preparations. Some of the key brands through which the company markets its products are; Rhino, Binafin, Kezolin, Hepalin, Progut, and Vomistat among others. Geographically, it carries out sales in India and outside India; generating key revenue from outside India.

Lincoln Pharmaceuticals Headlines

No Headlines